Faeth Therapeutics (SNSE) Live Share Price, Invest From India

Faeth Therapeutics Stock Performance

as on June 16, 2026 at 2:15 pm IST

Day's Low
Day's High
$13.76
Day's Price Range
$16.52
$13.85
0.65%
Downside
19.28%
Upside
52 Week's Low
52 Week's High
$7.45
52-Week Price Range
$36.76
$13.85
46.21%
Downside
165.42%
Upside

Faeth Therapeutics share price movements today

Previous Close: $13.00
Open: $15.41
Volume: 349.1K
Day's Low - High: $13.76 - $16.52
52 Week Low - High: $7.45 - $36.76

Faeth Therapeutics Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Faeth Therapeutics Stock Fundamentals & Key Indicators

Check Faeth Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Faeth Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Faeth Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Faeth Therapeutics	Buy	$-	NA	NA	0.00%	0.00%
Alnylam Pharma	StrongBuy	$30.3B	45.65%	37.18	79.72%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Analyst Recommendation on Faeth Therapeutics Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Faeth Therapeutics. Average target price of $52.5

Faeth Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Faeth Therapeutics.

What analysts predicted

73.62%UPSIDE

Target Price

$52.5

Current Price

$13.85

Analyzed by

10 Analysts

Target

$52.50

Faeth Therapeutics target price $52.5, a slight upside of 73.62% compared to current price of $13.85. According to 10 analysts rating.

Faeth Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	-	-	-	0	-	-	-4	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	-132
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-7	-7	-7	-7	-6	-4	-4	-4	-170
Net Profit Margin	-260.51%	0.00%	0.00%	0.00%	-1428.31%	0.00%	0.00%	94.19%	0.00%	0.00%

Faeth Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-1	0	0	-
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-13	-16	-20	-36	-48	-34	-30	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Faeth Therapeutics

Check out the Institutions with significant holdings in Faeth Therapeutics.

Funds	Holdings
Bridgeway Capital Management, LLC	0.00%
Geode Capital Management, LLC	0.71%
Cormorant Asset Management, LLC	22.85%
Logos Global Management LP	2.24%
BOOTHBAY FUND MANAGEMENT, LLC	1.95%

See all

Insights on Faeth Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SNSE has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Sensei Biotherapeutics, Inc. Common Stock has experienced a drawdown of -51.5%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 29.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, SNSE stock has moved down by -36.4%

About Faeth Therapeutics

Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. The Company's lead program is PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. The Company is also completing a Phase I/II trial of solnerstotug, its V-domain Ig suppressor of T cell activation (VISTA) inhibitor, in patients with advanced solid tumors. Its TMAb platform is designed to enable highly selective targeting through conditional antibody activation of immune cells in the tumor microenvironment without on-target, off-tumor activity. Its programs include Solnerstotug (SNS-101), SNS-102, SNS-103, and SNS-201. Solnerstotug is a conditionally active, human monoclonal IgG1 antibody designed to block the VISTA checkpoint, which acts as a suppressor of T cells by binding the receptor PSGL-1.

Organisation

Faeth Therapeutics

FAQs

What is Faeth Therapeutics share price today?

Faeth Therapeutics share price today is $13.85 as on June 16, 2026 at 8:45 am IST at the close of the market. Faeth Therapeutics share today touched a day high of $16.52 and a low of $13.76.

What is the 52 week high and 52 week low for Faeth Therapeutics share?

Faeth Therapeutics share touched a 52 week high of $36.76 on February 25, 2026 and a 52 week low of $7.45 on December 5, 2025. Faeth Therapeutics stock price today i.e. June 16, 2026 at 8:45 am IST is closed at $13.85,which is 62.32% down from its 52 week high and 85.91% up from its 52 week low.

How to invest in Faeth Therapeutics Stock (SNSE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Faeth Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Faeth Therapeutics Stock (SNSE) from India?

Indian investors can start investing in Faeth Therapeutics (SNSE) shares with as little as ₹94.94999694824219 or $1 (as of November 2, 2026 at 1:25 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Faeth Therapeutics stock (as per the Rupee-Dollar exchange rate as on November 2, 2026 at 1:25 am IST). Based on Faeth Therapeutics share’s latest price of $13.85 as on June 16, 2026 at 8:45 am IST, you will get 0.7220 shares of Faeth Therapeutics. Learn more about fractional shares .